FDA’s Top Vaccine Official resigns – Issues sharp criticism of Kennedy

FDA’s Top Vaccine Official is leaving his post while simultaneously criticizing the country’s health secretary for allowing “misinformation and lies” to influen...

Svenskutvecklad ”symaskin” för kirurgi godkänns i USA

Skånebaserade Suturion, som utvecklar ett slags symaskin för förbättrad bukkirurgi, har fått sin produkt FDA-godkänd och nu väntar lansering i USA.

ZEISS unveils AI-powered Research Data Platform

Collaboration with Boehringer Ingelheim champions the future of personalized eye care.

From pharmacist to life science podcaster – Magnus Lejelöv uses his voice as a tool

Magnus Lejelöv has more than 20 years of experience in the pharmaceutical industry and has conducted nearly two hundred interviews with healthcare professionals...

Leqembi får nobben i Australien – igen

Alzheimerläkemedlet Leqembi (lekanemab) nekas återigen marknadsgodkännande i Australien.

Career coach on salaries: “There is no right or wrong”

What is a reasonable salary for my job? It's a question we all ask ourselves. But how important is a higher salary really? Career coach Tina Persson believes th...

Stora tidskriftsförlag stämda – ”Pengar har dikterat möjligheten att nå ut med forskning”

Just nu pågår en rättsprocess i USA mot sex stora förlag för vetenskapliga tidskrifter. En grupp forskare hävdar att förlagen ”konspirerat” på ett sätt som förh...

Tools of Science

Joy at Egetis after positive CHMP opinion – ”The single most important milestone”

Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved treatment for the rare disease MCT8 deficiency."

Merck Life Science A/S

Your solution for right part positioning

ZEISS OmniFix CT - right part positioning solution to get meaningful measuring results for all part sizes.

Björn Arvidsson will lead research and innovation in Region Uppsala

The Swedish life science profile Björn Arvidsson has been appointed Director of Research and Innovation for Region Uppsala.

Misstänkt koppling mellan Ozempic och ögonsjukdom – myndighet reagerar

Två nya danska studier har pekat på en koppling mellan Ozempic (semaglutid) och en möjlig risk för den sällsynta ögonsjukdomen NAION. Nu vill danska läkemedelsv...

Assignment: Facilitate the retention of foreign researchers

A newly appointed public inquiry is to develop measures to make attracting and retaining foreign doctoral students and researchers in Sweden easier.

What will be the next big hype after obesity? – An expert panel highlighted their top picks

What will be the next big trend in life science? Everything from Alzheimer’s, Crispr and Omics were highlighted when the issue was debated at this year’s major ...

Rising interest in CRISPR treatments

Treatments using CRISPR technology are emerging as one of the hottest medical trends in the United States – and the FDA is doing its best to promote the development.

Stark uppgång för Crispr-behandlingar

Behandlingar som använder gensaxen Crispr växer fram som en av de hetaste medicinska trenderna i USA – och läkemedelsmyndigheten FDA gör sitt bästa för att stöd...

Introducing ZEISS arivis Pro 4.2

ZEISS arivis software enhances custom microscopy image analysis.

Scale Up Your Image Analysis

ZEISS arivis Hub for accelerated analysis and faster results.

Scientific Solutions

Advancing Drug Discovery by Combining Complex In-Vitro Models with AI-Powered 3D/4D Image Analysis

Free webinar organized by ZEISS.

JMP Statistical Discovery

AI detects tumor disease – via voice recording

A short voice recording along with facial images – both analyzed with an AI algorithm – can make it possible to detect the rare tumour disease acromegaly and in...

TECHNIA AB